BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Argus Health
Cantor Fitzgerald
Boehringer Ingelheim
UBS
Accenture
Cerilliant
Deloitte
Cipla

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064047

« Back to Dashboard

NDA 064047 describes NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, which is a drug marketed by Amring Pharms, Bausch And Lomb, Ipharm, and Watson Labs, and is included in four NDAs. It is available from six suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 064047
Pharmacology for NDA: 064047
Suppliers and Packaging for NDA: 064047
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 064047 ANDA Major Pharmaceuticals 0904-3016 0904-3016-10 1 BOTTLE, DROPPER in 1 CARTON (0904-3016-10) > 10 mL in 1 BOTTLE, DROPPER
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 064047 ANDA Rebel Distributors Corp 21695-528 21695-528-10 1 BOTTLE, DROPPER in 1 CARTON (21695-528-10) > 10 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
Approval Date:Jan 31, 1996TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Chinese Patent Office
Chubb
Argus Health
Dow
US Army
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot